Our Product Range

 

Product

Quality

Application

Regulatory

Documentation

NicSelect®
Nicotine EP / USP
Premium grade pure nicotine cGMP Pharma USDMF, EDMF, REACH Technical data sheet MSDS,
GMP certificate
cGMP E-liquids USDMF, EDMF,
REACH, TPD
Technical data sheet
MSDS, GMP certificate
Nicselect®
Nicotine blend
Standard blend:
100 mg/ml
Premium grade nicotine blends ‘ready to flavor’ cGMP E-liquids USDMF, EDMF, REACH Technical data sheet
MSDS, GMP certificate
Nicotine Bitartrate Dihydrate A pure crystalline salt of nicotine in powder format cGMP Pharma USDMF, EDMF Technical data sheet
MSDS, GMP certificate
Tobacco Absolute An original base flavor for a real cigarette taste cGMP E-liquids USDMF, EDMF Technical data sheet
MSDS, GMP certificate
Nicotine Resinate / Nicotine Polacrilex A nicotine ion-exchange resin complex for controlled nicotine release to the body cGMP Pharma USDMF, EDMF Technical data sheet
MSDS, GMP certificate

Applications

Alchem International is a leading global manufacturer of natural nicotine and nicotine complexes for use in Tobacco substitutes, including e-cigarettes, nicotine patches, nicotine gums and nicotine lozenges. Alchem NicSelect® premium nicotine is used extensively in e-cigarettes and other nicotine replacement products throughout Europe, the Unites States and the rest of the world.


e-cigarettes

Since their introduction in 2006, e-cigarettes have reached an estimated global market value of 3 billion USD in 2014. With their exceptional growth and popularity, e-cigarettes have posed a challenge to other smoking cessation products as well as to the tobacco cigarette industry. 1Their rapid growth is expected to continue as consumers chose to avoid tobacco products. As of 2016, with the application of the European TPD (Tobacco Product Directive), the e-liquid and e-cigarette market will be more regulated to ensure a consistent product quality and provide a reference for European consumers. In the US, the next several months will be a challenge for many of Nicotine retailers you as you prepare to adhere to the FDA regulations and the PMTA (pre-market tobacco approval) requirements.

Alchem International NicSelect® liquid nicotine is manufactured to the highest possible quality standards under pharmaceutical GMP conditions and subject to rigorous analytical controls to ensure the highest purity and lowest impurity levels. This ensures compliance with even the strictest regulations as well as guarantees outstanding quality and consistency. We are REACH and TPD compliant for Europe and will soon be submitting a TPMF (tobacco products master file) on NicSelect® to the FDA that you can reference in your PMTA applications for the US.


Patches, gums & lozenges

The global market size of nicotine replacement therapy (NRT) products reached just above 3 billion USD in 2014 – an increase of almost 300% in a decade. The most common forms are gums, inhalers, lozenges, nasal sprays, skin patches. Today, the market size is similar to those of e-cigarettes and is still growing strongly as new delivery devices are developed and consumers are looking for alternatives to their current tobacco products.

Alchem International produces pharmaceutical-grade liquid nicotine and nicotine powder complexes specifically for these applications in cGMP certified facilities and supported by Drug Master Files (DMFs) for medicinal registration.


We are committed to the long-term success of this industry. Please feel free to Contact Us to discuss how we can help you succeed in this ever-changing regulatory landscape.

1 ©2015 Transparency Market Research, All Rights Reserved